The offer is the latest in a series of deals by Concentra, an entity controlled by Tang Capital Partners, to buy struggling ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives ...

BMS entered the radiopharma space via its $4.1 billion buyout of RayzeBio at the end of 2023. Unlike Novartis’ approved ...

So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally ...

January kicked off the year with a flurry of notable leadership transitions across the pharmaceutical and biotechnology sectors. Here is a detailed look at the latest hires and departures.

please reach out to the Fierce Biotech editorial team and let us know. June 10 - Recursion Pharmaceuticals: The AI biotech is laying off a fifth of its workforce in connection with a previously ...

Blue Water Acquisition Corp. III has priced its initial public offering of 22M units at $10.00 each to raise $220M.

Some of these drugs will never hit the shelf of pharmaceuticals even after countless clinical trials. On the other hand, if a biotech company gets a new drug sanctioned by the FDA and the demand ...

MoonLake Immunotherapeutics shares surged 31% after the Financial Times reported, citing unnamed sources, that the company had rejected an initial acquisition offer by Merck & Co. for more than $3 ...

The 2025 STATUS List features 50 influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech. The list is wide-ranging ...